Refractory gastroesophageal reflux disease

Arquivos de Gastroenterologia

Volumn 49, Issue 4, 2012, Pages 296-301

  Moraes Filho, Joaquim Prado P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gastroesophageal reflux, drug therapy; Proton pump inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ASCORBIC ACID; DOXYCYCLINE; ENALAPRIL; ESOMEPRAZOLE; FERROUS SULFATE; FLUOXETINE; FLUTICASONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LANSOPRAZOLE; METFORMIN; MONTELUKAST; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; POTASSIUM CHLORIDE; QUINIDINE; RABEPRAZOLE; SIBUTRAMINE; STEROID; TETRACYCLINE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; AUTOIMMUNE SKIN DISEASE; COUGHING; DEPRESSION; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; DIGESTIVE TRACT ENDOSCOPY; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG TREATMENT FAILURE; DYSPEPSIA; EOSINOPHILIC ESOPHAGITIS; EPIGASTRIC PAIN; ESOPHAGITIS; ESOPHAGUS MANOMETRY; GASTROESOPHAGEAL REFLUX; GENOTYPE; HEARTBURN; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; NAUSEA; NAUSEA AND VOMITING; OBESITY; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PEPTIC ULCER; REVIEW; STOMACH SCINTISCANNING; TREATMENT RESPONSE; XEROSTOMIA;

EID: 84874305012     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032012000400012     Document Type: Review

References (21)

1. Abid S, Mumtaz K, Jafri W, Hamid S, Abbas Z, Shah HA, Khan A H. Pill induced esophageal injury: endoscopic features and clinical outcomes. Endoscopy. 2005;37:470-4.
2. Ahlawat SK, Mohi-Ud-Din R, Williams DC, Maher K, Benjamin S. A prospective study of gastric acid analysis and esophageal acid exposure in patients with gastroesophageal reflux refractory to medical therapy. Dig Dis Sci. 2005;50:2019-24. (Pubitemid 41504083)
3. Atkins D, Kramer R, Capocelli K, Lovell M, Furuta GT. Eosinophilic esophagitis: the newest esophageal inflammatory disease. Nat Rev Gastroenterol Hepatol. 2009;6:267-78.
4. Barrison AF, Jarboe LA, Weinberg BM, Nimmagadda K, Sullivan LM, Wolfe MM. Patterns of proton pump inhibitor use in clinical practice. Am J Med. 2001;111:469-73. (Pubitemid 33016419)
5. Boeckxstaens GE, Beaumont H, Mertens V, Denison H, Ruth M, Adler J, Silberg DG, Sifrim D. Effects of lesogaberan on reflux and lower esophageal sphincter functions in patients with gastroesophageal reflux disease. Gastroenterology. 2010;139:409-17.
6. Dal-Paz K, Moraes-Filho JPP, Navarro-Rodriguez T, Eisig JN, Barbuti R, Quigley EM. Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease. Dis Esophagus. 2012;25:107-13.
7. de Sousa Cury M, Ferrari AP, Ciconelli R, Ferraz MB, Moraes-Filho JPP. Evaluation of the health-related quality of life in gastroesophageal reflux disease patients before and after treatment with pantoprazole. Dis Esophagus. 2006;19:289-93. (Pubitemid 44027094)
8. Domingues GR, Moraes-Filho JPP, Domingues AG. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes. Arq Gastroenterol. 2011;48:24-9.
9. Furuta T, Shirai N, Watanabe F, Honda S, Takeushi K, Iida T, Sato Y, Kajimura M, Futami H, Takayanagi S, Yamada M, Ohashi K, Ishizaki T, Hanai H Effect of the cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin Pharmacol Ther 2002;72:453-60. (Pubitemid 35178870)
10. Galmiche JP, Clouse RE, Balint A, Cook IJ, Kahrilas PJ, Paterson WG, Smout AJ. Functional esophageal disorders. Gastroenterology. 2006;130:1459-65.
11. Gerson LB, Huff FJ, Hila A, Hirota WK, Reilley S, Agrawal A, Lai R, Luo W, Castell D. Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2010;105:1266-75.
12. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-esophageal reflux refractory to proton pump inhibitors. Gut. 2003;52:1397-402. (Pubitemid 37176716)
13. Konikoff M R, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier, Akers R, Cohen MB, Collins MH, Assa'ad A, Acevess SS, Putnam PE, Rothenberg ME. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006; 131:1381-91. (Pubitemid 44780861)
14. Moraes-Filho JP, Chinzon D, Eisig J, Hashimoto CL, Zaterka S. Prevalence of heartburn and gastroesophageal reflux disease in the urban Brazilian population. Arq Gastroenterol. 2005;42:122-7. (Pubitemid 41134023)
15. Moraes-Filho JP, Navarro-Rodriguez T, Eisig JN, Barbuti RC, Chinzon D, Quigley EM. Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital. Clinics. 2009;64:785-90.
16. Moraes-Filho JPP, Navarro-Rodriguez T, Barbuti R, Eisig J, Chinzon D, Bernardo W; Brazilian Gerd Consensus Group. Guidelines for the diagnosis and management of gastrosophageal reflux disease: an evidence-based consensus. Arq Gastroenterol. 2010;47:99-115.
17. Richter J. How to manage refractory GERD. Nat Clin Pract Gastroenterol Hepatol. 2007;4:658-64. (Pubitemid 350193815)
18. Sifrim D, Holloway R, Silny J, Xin Z, Tack J, Lerut A, Janssen J. Acid, nonacid, and gas reflux in patients with gastroesophageal disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001;120:1588-98. (Pubitemid 32523478)
19. Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, Bussmann C, Beglinger C, Schoepfer A, Simon HU. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526-37.
20. Vakil van N, Zanten S, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101:1900-20.
21. Zerbib F, Roman S, Ropert A, des Yarannes SB, Pouderoux P, Chaput U, Mion F, Vérin E, Galmiche JP, Sifrim D. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006;101:1956-63. (Pubitemid 44337616)